
07/08/2025
Chiar daca ai primit tratament antiviral pentru hepatita C, si virusul este negativ, ramane totusi riscul mare de dezvoltare de cancer de ficat, daca se asociază cu: fibroza hepatică- mai mult de 25 kPa; prezenta cirozei la începutul tratamentului, asocierea cu steatoza hepatică, varsta mai mare de 50 ani, sexul masculin.
Supravegherea este esențială la pacienții cu boala hepatică avansată!
📜 Title: Long-term Risk of Hepatic and Extrahepatic Related-Events after Direct Antiviral Therapy for Chronic Hepatitis C: A Prospective Long-term Study Cohort
✍ by Luisa Cavalletto, et al.
Website 📌: https://shorturl.at/dnBYv
-This study gave us the opportunity to produce a new algorithm to identify cases that, after HCV eradication with DAA, remain at high-risk of hepatic and extrahepatic events and, in particular, ofhepatocellular carcinoma (HCC).
-Patients with cirrhosis and portal hypertension (PH) maintained higher liver stiffness measures (LSM) and developed events in 74% of cases, even after successful long-term DAA therapy.
-Cases with RISS score ≥ 8 have had a significant incidence of HCC (80.4%) and a survival rate of 65.4% at 5-year.